BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

As of January 16, 2026, BYSI stock price declined to $1.71 with 11,140 million shares trading.

BYSI has a beta of -0.27, meaning it tends to be less sensitive to market movements. BYSI has a correlation of 0.00 to the broad based SPY ETF.

BYSI has a market cap of $70.32 million. This is considered a Micro Cap stock.

In the last 3 years, BYSI traded as high as $4.00 and as low as $.65.

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): VXF, VTI, IWC.

BYSI has underperformed the market in the last year with a return of +1.8%, while the SPY ETF gained +18.1%. In the last 3 month period, BYSI fell short of the market, returning -4.2%, while SPY returned +5.0%. However, in the most recent 2 weeks BYSI has outperformed the stock market by returning +6.2%, while SPY returned +1.2%.

BYSI support price is $1.63 and resistance is $1.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.